Hypothalamic-prolactin axis regulation in major depressed patients with suicidal behavior. (May 2023)
- Record Type:
- Journal Article
- Title:
- Hypothalamic-prolactin axis regulation in major depressed patients with suicidal behavior. (May 2023)
- Main Title:
- Hypothalamic-prolactin axis regulation in major depressed patients with suicidal behavior
- Authors:
- Duval, Fabrice
Mokrani, Marie-Claude
Danila, Vlad
Lopera, Felix Gonzalez
Erb, Alexis
Tomsa, Mihaela - Abstract:
- Abstract: Background: So far, little is known about the control of hypothalamic-prolactin axis activity by dopamine (DA) and thyrotropin-releasing hormone (TRH) in depressed patients with suicidal behavior disorder (SBD). Methods: We evaluated prolactin (PRL) responses to apomorphine (APO; a DA direct receptor agonist) and 0800 h and 2300 h protirelin (TRH) tests in 50 medication-free euthyroid DSM-5 major depressed inpatients with SBD (either current [n = 22], or in early remission [n = 28]); and 18 healthy hospitalized controls (HCs). Results: Baseline (BL) PRL levels were comparable across the three diagnostic groups. SBDs in early remission did not differ from HCs regarding PRL suppression to APO (PRL s ), PRL stimulation to 0800 h and 2300 h TRH tests (∆PRL), and ∆∆PRL values (difference between 2300 h-∆PRL and 0800 h-∆PRL values). Current SBDs showed lower PRL s and ∆∆PRL values than HCs and SBDs in early remission. Further analyses revealed that current SBDs with a history of violent and high-lethality suicide attempts were more likely to exhibit co-occurrence of low ∆∆PRL and PRL S values. Conclusions: Our results suggest that regulation of the hypothalamic-PRL axis is impaired in some depressed patients with current SBD, particularly those who have made serious suicide attempts. Considering the limitations of our study, our findings support the hypothesis that decreased pituitary D2 receptor functionality (possibly adaptive to increased tuberoinfundibular DAergicAbstract: Background: So far, little is known about the control of hypothalamic-prolactin axis activity by dopamine (DA) and thyrotropin-releasing hormone (TRH) in depressed patients with suicidal behavior disorder (SBD). Methods: We evaluated prolactin (PRL) responses to apomorphine (APO; a DA direct receptor agonist) and 0800 h and 2300 h protirelin (TRH) tests in 50 medication-free euthyroid DSM-5 major depressed inpatients with SBD (either current [n = 22], or in early remission [n = 28]); and 18 healthy hospitalized controls (HCs). Results: Baseline (BL) PRL levels were comparable across the three diagnostic groups. SBDs in early remission did not differ from HCs regarding PRL suppression to APO (PRL s ), PRL stimulation to 0800 h and 2300 h TRH tests (∆PRL), and ∆∆PRL values (difference between 2300 h-∆PRL and 0800 h-∆PRL values). Current SBDs showed lower PRL s and ∆∆PRL values than HCs and SBDs in early remission. Further analyses revealed that current SBDs with a history of violent and high-lethality suicide attempts were more likely to exhibit co-occurrence of low ∆∆PRL and PRL S values. Conclusions: Our results suggest that regulation of the hypothalamic-PRL axis is impaired in some depressed patients with current SBD, particularly those who have made serious suicide attempts. Considering the limitations of our study, our findings support the hypothesis that decreased pituitary D2 receptor functionality (possibly adaptive to increased tuberoinfundibular DAergic neuronal activity) together with decreased hypothalamic TRH drive might be a biosignature for high-lethality violent suicide attempts. Graphical Abstract: ga1 Highlights: Hypothalamic dopamine and TRH function is altered in depressed patients with a history of serious suicide attempts. Disinhibition of TIDA neurons associated with decreased TRH drive could be predictive of serious suicide attempts. Unaltered dopamine and TRH function could reflect a protective biological process against serious suicide attempts. … (more)
- Is Part Of:
- Psychoneuroendocrinology. Volume 151(2023)
- Journal:
- Psychoneuroendocrinology
- Issue:
- Volume 151(2023)
- Issue Display:
- Volume 151, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 151
- Issue:
- 2023
- Issue Sort Value:
- 2023-0151-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-05
- Subjects:
- Depression -- Suicidal behavior disorder -- Prolactin -- Dopamine -- Apomorphine -- Thyrotropin-releasing hormone (TRH)
Psychoneuroendocrinology -- Periodicals
Endocrinology -- Periodicals
Neurology -- Periodicals
Psychiatry -- Periodicals
Neuropsychoendocrinologie -- Périodiques
616.8 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03064530 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/03064530 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/03064530 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.psyneuen.2023.106050 ↗
- Languages:
- English
- ISSNs:
- 0306-4530
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6946.540300
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26815.xml